Genome Explorations Awarded Phase II SBIR Funding From NIAAA

Genome Explorations Inc. of Memphis TN. has been awarded a $830,000 Phase II Small Business Innovation Research grant from the National Health Institute’s Alcohol Abuse and Addiction Branch. The funding is provided to help Genome Explorations develop more sensitive and informative biomarkers for chronic alcohol use and alcohol-induced organ damage to facilitate earlier diagnosis and detection of pathologies caused by problematic drinking. We have been very fortunate to have received two Phase I funding rounds over the past two years from NIAAA which have helped us develop an extensive correlational database GenExQTL said Genome Explorations CEO and Founder Dr. Divyen Patel. All work will be conducted at Genome Explorations New 7000 square foot facility in Memphis TN and also at the University of Tennessee Health Sciences Center. Genome Explorations Provides Biotech, Pharmaceutical and Academic institutes with a Complete Solution for Genotyping and Gene Expression Analysis using the Affymetrix Platform.

Suggested Articles

Half of patients in an early trial of Allogene's off-the-shelf CAR-T cells for lymphoma who received a higher dose of its antibody ALLO-647 responded.

Takeda is tossing out a Shire pipeline med after it couldn't find a buyer.

Ipsen's new hire arrives at a company reeling from a torrent six months that have crushed hopes for its $1 billion bet on a rare disease drug.